MT-031

N/A

Report date: 2025/01/26 17:12:41
NME

Base Information

Drug NameMT-031
Drug Alias Namedual MAO-A/cholinesterase inhibitor (Technion-Israel Institute of Technology/Youdim Pharmaceuticals)MAO-A/AChE/BuChE inhibitor (Technion-Israel Institute of Technology/Youdim Pharmaceuticals)MT-031
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsMonoamine oxidase A inhibitors
TargetsMonoamine oxidase AAcetylcholinesterase
Therapy Area/IndicationsAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTechnion-Israel Institute Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesYoudim PharmaceuticalsTechnion-Israel Institute Of Technology
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A